Felbinac

Felbinac is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain and inflammation. It is effective in alleviating symptoms associated with rheumatoid arthritis, osteoarthritis, and other musculoskeletal disorders. Felbinac works by inhibiting the production of prostaglandins, which are chemical messengers that cause inflammation, pain, and fever.
As a selective COX-2 inhibitor, Felbinac targets the enzyme cyclooxygenase-2 (COX-2) without affecting the COX-1 enzyme. This selectivity reduces the risk of gastrointestinal side effects, such as ulcers and bleeding, often associated with other NSAIDs. However, Felbinac may still cause other side effects, including headache, dizziness, and nausea.
Follow the prescribed dosage and instructions for Felbinac use. The medication is available in tablet form and is typically taken orally with or without food. To ensure the best results, patients should consult with their healthcare provider to discuss the appropriate dosage and duration of treatment based on their individual needs and medical history.
Felbinac should not be used by individuals with a history of allergic reactions to NSAIDs, as well as those with severe kidney or liver impairment. Additionally, pregnant or breastfeeding women should avoid using Felbinac unless explicitly advised by a healthcare professional.